Circular RNAs as emerging players in cervical cancer tumorigenesis; A review to roles and biomarker potentials
- PMID: 35318084
- DOI: 10.1016/j.ijbiomac.2022.03.103
Circular RNAs as emerging players in cervical cancer tumorigenesis; A review to roles and biomarker potentials
Abstract
Cervical cancer is the most lethal gynecological cancer among women worldwide. Most of the patients are diagnosed at the advanced stages due to late diagnosis and lack of accessible and valuable approaches for early detection of the disease. Circular RNAs (circRNAs) are a distinguishable class of non-coding RNAs with characteristic loop structures. Although their function has not been completely elucidated; however, recent evidence has suggested regulatory functions for circRNAs on gene expression controlling various biological functions like cell growth and apoptosis, development, embryogenesis, and pathogenesis of human diseases particularly cancers. Studies show the role of dysregulated circRNAs in biological processes including cell proliferation, migration, invasion, apoptosis, angiogenesis, and chemoresistance contributing to affect tumorigenesis in ovarian cancer cells, animal, and clinical studies. These effects can be defined as consistent with several tumorigenesis characteristics, which are defined as "hallmarks of cancer". Additionally, dysregulated circRNAs exhibit prognostic, and diagnostic potentials both in the prediction of prognosis in ovarian cancer patients, and also their discrimination from healthy individuals. Furthermore, targeting circRNAs has shown positive results in the suppression of malignant features of cancer cells, and also in overcoming chemoresistance. In this review, I have gathered the majority of studies evaluating the role of circRNAs in the development, and progression of cervical cancer, and also have discussed prognostic, diagnostic, and therapeutic potentials of circRNAs for clinical applications in cervical cancer patients.
Keywords: Biomarker; Cervical cancer; Circular RNA; Invasion; Proliferation.
Copyright © 2022 Elsevier B.V. All rights reserved.
Similar articles
-
Riddle of the Sphinx: Emerging role of circular RNAs in cervical cancer.Pathol Res Pract. 2024 May;257:155315. doi: 10.1016/j.prp.2024.155315. Epub 2024 Apr 17. Pathol Res Pract. 2024. PMID: 38653090 Review.
-
Circular RNAs: A novel biomarker for cervical cancer.J Cell Physiol. 2020 Feb;235(2):718-724. doi: 10.1002/jcp.29009. Epub 2019 Jun 25. J Cell Physiol. 2020. PMID: 31240697 Review.
-
Circular RNAs: Novel biomarkers for cervical, ovarian and endometrial cancer (Review).Oncol Rep. 2020 Nov;44(5):1787-1798. doi: 10.3892/or.2020.7780. Epub 2020 Sep 25. Oncol Rep. 2020. PMID: 33000238 Free PMC article. Review.
-
Dysregulated expression of circular RNAs serve as diagnostic and prognostic markers in ovarian and cervical cancer: A PRISMA-compliant systematic review and meta-analysis.Medicine (Baltimore). 2021 Oct 1;100(39):e27352. doi: 10.1097/MD.0000000000027352. Medicine (Baltimore). 2021. PMID: 34596142 Free PMC article.
-
The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.Cell Death Dis. 2019 Dec 12;10(12):950. doi: 10.1038/s41419-019-2183-z. Cell Death Dis. 2019. PMID: 31831728 Free PMC article.
Cited by
-
Targeting Non-Coding RNA for CNS Injuries: Regulation of Blood-Brain Barrier Functions.Neurochem Res. 2023 Jul;48(7):1997-2016. doi: 10.1007/s11064-023-03892-1. Epub 2023 Feb 14. Neurochem Res. 2023. PMID: 36786944 Review.
-
Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.Clin Exp Med. 2024 May 2;24(1):93. doi: 10.1007/s10238-024-01355-7. Clin Exp Med. 2024. PMID: 38693424 Free PMC article. Review.
-
Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer.Discov Oncol. 2023 May 10;14(1):65. doi: 10.1007/s12672-023-00674-7. Discov Oncol. 2023. PMID: 37160813 Free PMC article. Review.
-
Circular circRANGAP1 Contributes to Non-small Cell Lung Cancer Progression by Increasing COL11A1 Expression Through Sponging miR-653-5p.Biochem Genet. 2023 Dec;61(6):2580-2598. doi: 10.1007/s10528-023-10393-x. Epub 2023 May 16. Biochem Genet. 2023. PMID: 37193942
-
Role of m6A modification and novel circ_0066715/ miR-486-5p/ ETS1 axis in rheumatoid arthritis macrophage polarization progression.Aging (Albany NY). 2022 Dec 20;14(24):10009-10026. doi: 10.18632/aging.204439. Epub 2022 Dec 20. Aging (Albany NY). 2022. PMID: 36541909 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical